Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA1
Rizzo, K.; Horwich-Scholefield, S.; Epson, E.
Emerging Infectious Diseases 25(7): 1389-1393
2019
ISSN/ISBN: 1080-6059
PMID: 31211678
DOI: 10.3201/eid2507.181938
Accession: 069068148
We analyzed antimicrobial susceptibility test results reported in healthcare-associated infections by California hospitals during 2014-2017. Approximately 3.2% of Enterobacteriaceae reported in healthcare-associated infections were resistant to carbapenems and 26.9% were resistant to cephalosporins. The proportion of cephalosporin-resistant Escherichia coli increased 7% (risk ratio 1.07, 95% CI 1.04-1.11) per year during 2014-2017.
PDF emailed within 0-6 h: $19.90
Related References
Lodise, T.P.; Berger, A.; Altincatal, A.; Wang, R.; Bhagnani, T.; Gillard, P.; Bonine, N.G. 2019: Antimicrobial Resistance or Delayed Appropriate Therapy-Does one Influence Outcomes more than the other Among Patients with Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae? Open Forum Infectious Diseases 6(6): Ofz194Reuben, J.; Donegan, N.; Wortmann, G.; DeBiasi, R.; Song, X.; Kumar, P.; McFadden, M.; Clagon, S.; Mirdamadi, J.; White, D.; Harris, J.E.; Browne, A.; Hooker, J.; Yochelson, M.; Walker, M.; Little, G.; Jernigan, G.; Hansen, K.; Dockery, B.; Sinatro, B.; Blaylock, M.; Harmon, K.; Iyengar, P.; Wagner, T.; Nelson, J.A. 2017: Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): a Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia Infection Control and Hospital Epidemiology 38(8): 921-929
Eser, O.K.ös.ğl.; Altun Uludağ, H.; Ergin, A.; Boral, B.ış; Sener, B.çi.; Hasçelik, G.ül.şe. 2014: Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections Mikrobiyoloji Bulteni 48(1): 59-69
Woodford, N.; Xu-McCrae, L.; Mushtaq, S.; Wu, H.H.T.; Ellington, M.J.; Lancaster, O.; Davies, F.; Donaldson, H.; Rao, G.G.; Verma, A.; Wareham, D.W.; Ciesielczuk, H.; Stone, G.G.; Irani, P.M.; Bracher, S.; Hawkey, P.M. 2018: Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK) Journal of Antimicrobial ChemoTherapy 73(3): 698-702
Senchyna, F.; Gaur, R.L.; Sandlund, J.; Truong, C.; Tremintin, G.; Kültz, D.; Gomez, C.A.; Tamburini, F.B.; Andermann, T.; Bhatt, A.; Tickler, I.; Watz, N.; Budvytiene, I.; Shi, G.; Tenover, F.C.; Banaei, N. 2019: Diversity of resistance mechanisms in carbapenem-resistant Enterobacteriaceae at a health care system in Northern California, from 2013 to 2016 Diagnostic Microbiology and Infectious Disease 93(3): 250-257
White, B.P.; Patel, S.; Tsui, J.; Chastain, D.B. 2019: Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections Infectious Diseases 51(3): 161-167
Cancelli, F.; Oliva, A.; De Angelis, M.; Mascellino, M.T.; Mastroianni, C.M.; Vullo, V. 2018: Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae: a Single-Center, Observational Study Biomed Research International 2018: 2785696
Lesho, E.P.; Clifford, R.J.; Chukwuma, U.; Kwak, Y.I.; Maneval, M.; Neumann, C.; Xie, S.; Nielsen, L.E.; Julius, M.D.; McGann, P.; Waterman, P.E. 2015: Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system Diagnostic Microbiology and Infectious Disease 81(2): 119-125
Shields, R.K.; Potoski, B.A.; Haidar, G.; Hao, B.; Doi, Y.; Chen, L.; Press, E.G.; Kreiswirth, B.N.; Clancy, C.J.; Nguyen, M.H. 2016: Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 63(12): 1615-1618
Anesi, J.A.; Lautenbach, E.; Nachamkin, I.; Garrigan, C.; Bilker, W.B.; Omorogbe, J.; Dankwa, L.; Wheeler, M.; Tolomeo, P.; Han, J.H. 2019: The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study Bmc Infectious Diseases 19(1): 163
Martin, A.; Fahrbach, K.; Zhao, Q.; Lodise, T. 2018: Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae : Results of a Systematic Literature Review and Meta-analysis Open Forum Infectious Diseases 5(7): Ofy150
Zerr, D.M.; Weissman, S.J.; Zhou, C.; Kronman, M.P.; Adler, A.L.; Berry, J.E.; Rayar, J.; Myers, J.; Haaland, W.L.; Burnham, C.-A.D.; Elward, A.; Newland, J.; Selvarangan, R.; Sullivan, K.V.; Zaoutis, T.; Qin, X. 2017: The Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin- and Carbapenem-Resistant Enterobacteriaceae at 4 US Pediatric Hospitals Journal of the Pediatric Infectious Diseases Society 6(4): 366-375
Shields, R.K.; Nguyen, M.H.; Chen, L.; Press, E.G.; Kreiswirth, B.N.; Clancy, C.J. 2018: Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections Antimicrobial Agents and ChemoTherapy 62(5)
Amladi, A.U.; Abirami, B.; Devi, S.M.; Sudarsanam, T.D.; Kandasamy, S.; Kekre, N.; Veeraraghavan, B.; Sahni, R.D. 2019: Susceptibility profile, resistance mechanisms and efficacy ratios of fosfomycin, nitrofurantoin and colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections Indian Journal of Medical Research 149(2): 185-191
Ho, C-Mao.; Ho, M-Wang.; Liu, Y-Ching.; Toh, H-Siong.; Lee, Y-Lin.; Liu, Y-Meng.; Huang, C-Chang.; Lu, P-Liang.; Liu, C-Eng.; Chen, Y-Hsu.; Ko, W-Chien.; Tang, H-Jen.; Yu, K-Woon.; Chen, Y-Shen.; Chuang, Y-Ching.; Wang, J-Hsien.; Hsueh, P-Ren. 2012: Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010 International Journal of Antimicrobial Agents 40 Suppl: S24-S28